Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood

Cell Biochemistry and Biophysics

Volumn 39, Issue 2, 2003, Pages 89-99

  Carr Jr , Marcus E ^a,b,c,d,e   Angchaisuksiri, Pantep ^c,d   Carr, Sheryl L ^a,d   Martin, Erika J ^a,d  

^a Coagulation Special Studies Laboratory ^*  (United States)

^b Division of Hematology/Oncology   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antithrombin III; Argatroban; Bivalirudin; Hirudin; Lepirudin; P PACK II; Thrombomodulin; Thromstop

Indexed keywords

ANTITHROMBIN III; FIBRIN; FIBRINOLYTIC AGENT; HEPARIN; HEPARIN ANTAGONIST; PROTAMINE; THROMBIN;

ARTICLE; BLOOD CLOT RETRACTION; BLOOD CLOTTING; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; THROMBOCYTE;

ANTITHROMBIN III; BLOOD COAGULATION; BLOOD PLATELETS; CLOT RETRACTION; FIBRIN; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; PROTAMINES; THROMBIN;

EID: 2442570834     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1385/CBB:39:2:89     Document Type: Article

References (43)

1. Shattil, S. J. and Bennett, J. S. (1981) Platelets and their membranes in hemostasis: physiology and pathophysiology. Ann. Intern. Med. 94, 108-118.
2. Colman, R. W. (1984) Surface mediated defense reactions: the plasma contact activation system. J. Clin. Invest. 73, 1249-1953.
3. Radcliffe, R. and Nemerson, Y. (1974) Activation and control of factor X and thrombin: Isolation and characterization of a single chain form of factor VII. J. Biol. Chem. 250, 388-395.
4. Davie, E. W. and Ratnoff, O. D. (1964) Waterfall sequence for intrinsic blood clotting. Science 145, 1310-1311.
5. Suttie, J. W. and Jackson, C. M. (1977) Prothrombin structure, activation and biosynthesis. Physiol. Rev. 57, 1-70.
6. Majerus, P. W., Tollefson, D. M., and Shuman, M. A. The interaction of platelets with thrombin, in Platelets in Biology and Pathology (Gordon J. L., ed.). North-Holland Pubishing, Amsterdam, 1976, pp. 241-260.
7. Hermans, J. and McDonagh, J. (1982) Fibrin: Structure and interactions. Semin. Thromb. Hemost. 8, 11-24.
8. Nesheim, M. E. and Mann, K. G. (1979) Thrombin-catalyzed activation of single-chain bovine factor V. J. Biol. Chem. 254, 1326-1334.
9. Hatton, M. W. C., Berry, L. R., and Regoeczi, E. (1978) Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aorta. Thromb. Res. 13, 655-670.
10. Esmon, N. L., Owen, W. G., and Esmon, C. T. (1982) Isolation of a membrane-bound co-factor for thrombin-catalyzed activation of protein C. J. Biol. Chem. 257, 859-864.
11. Quick, A. J. (1935) The prothrombin in haemophilia and in obstructive jaundice. J. Biol. Chem. 109, 73-74.
12. Langdell, R. D., Wagner, R. H., and Brinkhous, K. M. (1953) Effect of antihaemophilic factor on one-stage clotting test. J. Clin. Med. 41, 637-647.
13. Carr, M. E. (1995) Measurement of platelet force: The Hemodyne® hemostasis analyzer. Clin. Lab. Management Rev. 9, 312-319.
14. Carr, M. E. and Zekert, S. L. (1991) Measurement of platelet-mediated force development during plasma clot formation. Am. J. Med. Sci. 302, 13-18.
15. Carr, M. E. and Zekert, S. L. (1991) Force monitoring of clot retraction during DDAVP therapy for the qualitative platelet disorder of uremia: Report of a case. Blood Coag. Fibrinol. 2, 303-308.
16. Carr, M. E., Shen, L. L., and Hermans, J. (1976) A physical standard of fibrinogen: Measurement of the elastic modulus of dilute fibrin gels with a new elastometer. Anal. Biochem. 72, 202-211.
17. Carr, M. E. (1993) Apparatus and method for measuring clot elastic modulus and force development on the same blood sample. U.S. Patent no. 5,205,159.
18. Carr, M. E. and Zekert, S. L. (1994) Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma. Am. J. Physiol. 266, H1195-H1201.
19. Carr, M. E., Carr, S. L., Hantgan, R. R., and Braaten, J. (1995) Glycoprotein IIb/IIIa blockade inhibits platelet-mediated force development and reduces gel elastic modulus. Thromb. Haemost. 73, 499-505.
20. Widmer, K., Moake, J. L., Kent, C. J., Yeo, Y. Y., and Reynolds, J. P. (1976) Clot retraction: Evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets. J. Lab. Clin. Med. 87, 49-57.
21. Moake, J. L., Cimo, P. L., Widmer, K., Peterson, D. M., and Gum, J. R. (1977) Effects of prostaglandins, derivatives of cyclic 3′:5′-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet rich plasma and gel-separated platelet test systems. Thromb. Haemost. 38, 420.
22. Jen, C. J. and McIntire, L. V. (1982) The structural properties and contractile force of a clot. Cell Motil. 2, 445-455.
23. de Gaetano, G., Bottecchia, D., and Vermylen, J. (1973) Retraction of reptilase-clots in the presence of agents inducing or inhibiting the platelet adhesion-aggregation reaction. Thromb. Res. 2, 71-84.
24. 1. Thromb. Res. 4, 189-192.
25. Carr, M. E., Carr, S. L., Tildon, T., Fisher, L. M., and Martin, E. J. (2003) Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies. J. Thromb. Haemost. 1, 243-249.
26. Carr, M. E., Carr, S. L., and Greilich, P. E. (1996) Heparin ablates force development during platelet mediated clot retraction. Thromb. Haemost. 75, 674-678.
27. Jesty, J. (1986) The kinetics of inhibition of alpha-thrombin in human plasma. J. Biol. Chem. 261, 10313-10318.
28. Hofsteenge, J., Taguchi, H., and Stone, S. R. (1986) Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. Biochem. J. 237, 243-251.
29. Krishnaswami, A., Carr, M. E., Jessie, R. L., Kontos, M., Minisi A. J., Ornato J. P., et al. (2002) Patients with coronary artery disease who present with chest pain have significantly elevated platelet contractile force and clot elastic modulus. Thromb. Haemost. 88, 739-744.
30. Carr, M. E. (2003) Development of platelet contractile force as a research and clinical measure of platelet function. Cell Biochem. Biophys. 38, 55-78.
31. Carr, M. E., Martin, E. J., Kuhn, J. G., and Spiess, B. D. (2003) Onset of force development as a marker of thrombin generation in whole blood: the Thrombin Generation Time (TGT). J. Thromb. Haemost. 1, 1977-1983.
32. Clauss, A. (1957) A rapid physiological coagulation method for determination of fibrinogen. Acta Haematol. 17, 237-246.
33. Carr, M. E. and Gabriel, D. A. (1980) The effect of dextran 70 on the structure of plasma-derived fibrin gels. J. Lab. Clin. Med. 96, 985-993.
34. Carr, M. E. and Gabriel, D. A. (1980) Dextran-induced changes in fibrin fiber size and density based on wavelength dependence of gel turbidity. Macromolecules 13, 1473-1477.
35. Carr, M. E. and Hermans, J. (1978) Size and density of fibrin fibers from turbidity. Macromolecules 11, 46-50.
36. Hockin, M. F., Jones, K. C., Everse, S. J., and Mann, K. G. (2002) A model for the stoichiometric regulation of blood coagulation. J. Biol. Chem. 277, 18322-18333.
37. Kjalke, M., Monroe, D. M., Hoffman, M., Oliver, J. A., Ezban, M., and Roberts, H. R. (1998) Active site-inactivated factors Vila, Xa, and Ixa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation. Thromb. Haemost. 80, 578-584.
38. Carr, M. E. and Carr, S.L. (1994) At high heparin concentrations, protamine concentrations which reverse heparin anticoagulant effects are insufficient to reverse heparin anti-platelet effects. Thromb. Res. 75, 617-630.
39. Carr, M. E. (1988) Fibrin formed in plasma is composed of fibers more massive than those formed from purified fibrinogen. Thromb. Haemost. 59, 535-539.
40. Okada, M. and Blombäck, B. (1983) Factors influencing fibrin gel structure studied by flow measurement. Ann. NY Acad. Sci. 408, 233-253.
41. Butenas, S., Cawthern, K. M., van't Veer, C., DiLorenzo, M. E., Lock, J. B., and Mann, K. G. (2001) Antiplatelet agents in tissue factor-induced blood coagulation. Blood 97, 2314-2322.
42. Beeck, H., Nagel, D., Pindur, G., Scharrer, I., Preiss, A., Seiler, D., and Hellstern, P. (2000) Measurement of antithrombin activity by thrombin-based and by factor Xa-based chromogenic substrate assays. Blood Coag. Fibrinol. 11, 127-135.
43. Carr, M. E. and Carr, S. L. (1995) Fibrin structure and concentration alter clot elastic modulus but do not alter platelet mediated force development. Blood Coag. Fibrinol. 6, 79-86.